NTLA insider buying
Every open-market purchase of Intellia Therapeutics, Inc. (NTLA) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$1.40M
Insiders buying (12m)1
Purchases on record1
Last purchase filedJan 7, 2026
In the last 12 months, 1 insider of Intellia Therapeutics, Inc. bought $1.40M of NTLA stock on the open market in 1 reported purchase. The most recent was filed on Jan 7, 2026: Cohen Fred E (Director) bought 150,000 shares at $9.35, worth $1.40M.
Get the next NTLA insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll NTLA insider purchases
| Filed | Insider | Value | Shares | Price | Stake | Trade | |
|---|---|---|---|---|---|---|---|
| Jan 7 | Cohen Fred EDirector | $1.40M | 150,000 | $9.35 | +261% | Jan 5 | SEC |